Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis
Status:
Completed
Trial end date:
2018-05-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of ocular iontophoresis with
dexamethasone phosphate ophthalmic solution EGP-437 using the EyeGate® II Drug Delivery
System (EGDS) compared to prednisolone acetate ophthalmic suspension (1%) in patients with
non-infectious anterior segment uveitis.